Steven Edmundowicz
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 39 | 2025 | 209 | 3.990 |
Why?
| | Endoscopy, Gastrointestinal | 29 | 2023 | 230 | 3.620 |
Why?
| | Endosonography | 30 | 2024 | 152 | 2.080 |
Why?
| | Bariatric Surgery | 12 | 2019 | 217 | 1.810 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 135 | 1.720 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 328 | 1.720 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 857 | 1.610 |
Why?
| | Endoscopy | 13 | 2020 | 320 | 1.460 |
Why?
| | Adenoma | 12 | 2023 | 219 | 1.460 |
Why?
| | Pancreatitis | 14 | 2025 | 133 | 1.380 |
Why?
| | Weight Loss | 11 | 2019 | 783 | 1.340 |
Why?
| | Gastric Balloon | 6 | 2018 | 17 | 1.340 |
Why?
| | Obesity | 17 | 2019 | 2962 | 1.310 |
Why?
| | Stents | 20 | 2025 | 526 | 1.270 |
Why?
| | Gastroplasty | 5 | 2019 | 32 | 1.250 |
Why?
| | Adenocarcinoma | 13 | 2023 | 885 | 1.120 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 130 | 1.120 |
Why?
| | Barrett Esophagus | 10 | 2022 | 154 | 1.070 |
Why?
| | Pancreatic Ducts | 11 | 2024 | 79 | 1.020 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 245 | 1.010 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 56 | 1.010 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 117 | 1.000 |
Why?
| | Drainage | 12 | 2024 | 173 | 0.980 |
Why?
| | Gastroenterology | 10 | 2019 | 177 | 0.920 |
Why?
| | Colonic Polyps | 7 | 2015 | 81 | 0.920 |
Why?
| | Colonoscopy | 12 | 2023 | 243 | 0.910 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 242 | 0.850 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 111 | 0.790 |
Why?
| | Cholestasis | 3 | 2020 | 205 | 0.720 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 206 | 0.700 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.670 |
Why?
| | Duodenum | 4 | 2019 | 74 | 0.670 |
Why?
| | Pancreatitis, Chronic | 5 | 2024 | 59 | 0.660 |
Why?
| | Esophagus | 8 | 2019 | 257 | 0.650 |
Why?
| | Pancreatic Pseudocyst | 5 | 2024 | 17 | 0.630 |
Why?
| | Humans | 161 | 2025 | 138651 | 0.630 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 66 | 0.630 |
Why?
| | Middle Aged | 93 | 2025 | 33604 | 0.630 |
Why?
| | Obesity, Morbid | 7 | 2019 | 271 | 0.620 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 29 | 0.620 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 70 | 0.610 |
Why?
| | Indomethacin | 4 | 2025 | 87 | 0.610 |
Why?
| | Catheterization | 9 | 2024 | 181 | 0.600 |
Why?
| | Aged | 72 | 2025 | 24024 | 0.580 |
Why?
| | Clinical Competence | 11 | 2020 | 1149 | 0.580 |
Why?
| | Learning Curve | 6 | 2019 | 70 | 0.540 |
Why?
| | Cross Infection | 1 | 2020 | 249 | 0.540 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 25 | 0.530 |
Why?
| | Radiation Exposure | 1 | 2017 | 53 | 0.530 |
Why?
| | Gastrostomy | 5 | 2019 | 118 | 0.520 |
Why?
| | Intestine, Small | 2 | 2020 | 156 | 0.520 |
Why?
| | Prospective Studies | 36 | 2024 | 7554 | 0.510 |
Why?
| | Colonic Diseases | 3 | 2013 | 35 | 0.510 |
Why?
| | Radiation Injuries | 1 | 2017 | 147 | 0.500 |
Why?
| | Jejunum | 2 | 2015 | 32 | 0.500 |
Why?
| | Treatment Outcome | 36 | 2025 | 10923 | 0.490 |
Why?
| | Smell | 1 | 2016 | 122 | 0.470 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 16 | 0.470 |
Why?
| | Male | 94 | 2025 | 68260 | 0.470 |
Why?
| | Pathology, Clinical | 1 | 2015 | 29 | 0.460 |
Why?
| | Cholelithiasis | 8 | 2010 | 37 | 0.460 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 75 | 0.460 |
Why?
| | Pancreas | 7 | 2021 | 322 | 0.450 |
Why?
| | Lithotripsy | 6 | 2024 | 46 | 0.450 |
Why?
| | Laparoscopy | 6 | 2020 | 454 | 0.450 |
Why?
| | Female | 96 | 2025 | 73763 | 0.450 |
Why?
| | Suction | 2 | 2017 | 32 | 0.440 |
Why?
| | Catheter Ablation | 5 | 2022 | 302 | 0.430 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 88 | 0.420 |
Why?
| | Esophagoscopy | 8 | 2022 | 210 | 0.410 |
Why?
| | Gallstones | 6 | 1996 | 33 | 0.410 |
Why?
| | Postoperative Complications | 11 | 2024 | 2722 | 0.400 |
Why?
| | Adult | 60 | 2025 | 38201 | 0.380 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1941 | 0.380 |
Why?
| | Propofol | 4 | 2023 | 88 | 0.370 |
Why?
| | Body Weight | 1 | 2016 | 992 | 0.370 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 4 | 2025 | 347 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2490 | 0.360 |
Why?
| | Biopsy | 5 | 2019 | 1072 | 0.360 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.350 |
Why?
| | Precancerous Conditions | 4 | 2017 | 165 | 0.350 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 777 | 0.350 |
Why?
| | Aged, 80 and over | 23 | 2025 | 7677 | 0.340 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 307 | 0.340 |
Why?
| | Bile Ducts | 5 | 2014 | 66 | 0.340 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 24 | 0.320 |
Why?
| | Ampulla of Vater | 3 | 2023 | 34 | 0.320 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 48 | 0.320 |
Why?
| | Cytodiagnosis | 2 | 2020 | 32 | 0.320 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 14 | 0.310 |
Why?
| | Insufflation | 1 | 2009 | 13 | 0.310 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 237 | 0.310 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 310 | 0.290 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 23 | 0.290 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 52 | 0.290 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 52 | 0.290 |
Why?
| | Retrospective Studies | 35 | 2025 | 15909 | 0.280 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.270 |
Why?
| | Carbon Dioxide | 1 | 2009 | 241 | 0.270 |
Why?
| | Decompression, Surgical | 2 | 2023 | 112 | 0.260 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 38 | 0.250 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 28 | 0.250 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 156 | 0.250 |
Why?
| | Quality of Life | 11 | 2024 | 2954 | 0.250 |
Why?
| | Pain, Postoperative | 1 | 2009 | 309 | 0.250 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 13 | 0.240 |
Why?
| | Pancreatectomy | 2 | 2021 | 244 | 0.240 |
Why?
| | Body Mass Index | 7 | 2019 | 2349 | 0.240 |
Why?
| | Thoracoscopy | 1 | 2006 | 58 | 0.240 |
Why?
| | Follow-Up Studies | 16 | 2015 | 5112 | 0.240 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 1057 | 0.230 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 109 | 0.230 |
Why?
| | Mental Recall | 1 | 2006 | 207 | 0.220 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 426 | 0.220 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 14 | 0.220 |
Why?
| | Polyvinyls | 1 | 2004 | 21 | 0.220 |
Why?
| | Societies, Medical | 3 | 2018 | 839 | 0.220 |
Why?
| | Magnets | 2 | 2015 | 20 | 0.210 |
Why?
| | Plastics | 3 | 2022 | 50 | 0.210 |
Why?
| | Gastric Bypass | 2 | 2017 | 118 | 0.200 |
Why?
| | Periodicals as Topic | 1 | 2006 | 212 | 0.200 |
Why?
| | Ablation Techniques | 3 | 2017 | 32 | 0.200 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.190 |
Why?
| | Internet | 2 | 2009 | 669 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.190 |
Why?
| | Fluoroscopy | 3 | 2019 | 166 | 0.190 |
Why?
| | Patient Satisfaction | 1 | 2006 | 688 | 0.190 |
Why?
| | Prostheses and Implants | 3 | 2013 | 143 | 0.180 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 17 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 267 | 0.180 |
Why?
| | Risk Factors | 14 | 2025 | 10252 | 0.170 |
Why?
| | Deglutition Disorders | 3 | 2019 | 148 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 38 | 0.170 |
Why?
| | Intestinal Perforation | 2 | 2018 | 44 | 0.170 |
Why?
| | Double-Blind Method | 7 | 2018 | 1949 | 0.170 |
Why?
| | Logistic Models | 7 | 2024 | 2065 | 0.170 |
Why?
| | Prosthesis Design | 3 | 2019 | 333 | 0.170 |
Why?
| | Varicose Veins | 1 | 2020 | 16 | 0.170 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 35 | 0.160 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 33 | 0.160 |
Why?
| | Anesthesia | 1 | 2023 | 245 | 0.160 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1372 | 0.160 |
Why?
| | Equipment Design | 6 | 2020 | 519 | 0.160 |
Why?
| | Cell-Free System | 1 | 2019 | 55 | 0.160 |
Why?
| | Abdominal Pain | 3 | 2019 | 142 | 0.160 |
Why?
| | Deep Sedation | 2 | 2010 | 17 | 0.160 |
Why?
| | Fiducial Markers | 1 | 2019 | 9 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2019 | 10 | 0.150 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 34 | 0.150 |
Why?
| | Watchful Waiting | 3 | 2019 | 77 | 0.150 |
Why?
| | Needles | 1 | 2019 | 62 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1567 | 0.150 |
Why?
| | Academic Medical Centers | 3 | 2023 | 514 | 0.150 |
Why?
| | Infection Control | 1 | 2020 | 165 | 0.140 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 55 | 0.140 |
Why?
| | Metals | 4 | 2023 | 140 | 0.140 |
Why?
| | Administration, Rectal | 3 | 2024 | 13 | 0.140 |
Why?
| | Abdomen | 2 | 2016 | 135 | 0.140 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.140 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3307 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.140 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 92 | 0.140 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 10 | 0.140 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 11 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2023 | 712 | 0.130 |
Why?
| | Suture Techniques | 3 | 2017 | 121 | 0.130 |
Why?
| | Simulation Training | 1 | 2019 | 110 | 0.130 |
Why?
| | Conscious Sedation | 2 | 2023 | 94 | 0.130 |
Why?
| | Calcinosis | 1 | 2019 | 238 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 127 | 0.130 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 496 | 0.130 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 110 | 0.130 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 94 | 0.130 |
Why?
| | Diet Therapy | 1 | 2016 | 37 | 0.130 |
Why?
| | Metaplasia | 4 | 2022 | 58 | 0.130 |
Why?
| | Immunoassay | 1 | 2017 | 111 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1047 | 0.120 |
Why?
| | Stomach | 1 | 2016 | 109 | 0.120 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 326 | 0.120 |
Why?
| | Population Surveillance | 2 | 2017 | 476 | 0.120 |
Why?
| | Young Adult | 11 | 2025 | 13305 | 0.120 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 26 | 0.120 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.120 |
Why?
| | Single-Blind Method | 5 | 2019 | 286 | 0.120 |
Why?
| | Referral and Consultation | 3 | 2019 | 793 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 77 | 0.120 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 620 | 0.120 |
Why?
| | Colon, Ascending | 1 | 2015 | 2 | 0.120 |
Why?
| | Dissection | 1 | 2015 | 53 | 0.120 |
Why?
| | Life Style | 2 | 2018 | 478 | 0.120 |
Why?
| | Dogs | 1 | 2016 | 426 | 0.110 |
Why?
| | Documentation | 1 | 2017 | 198 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 310 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 57 | 0.110 |
Why?
| | Cholecystectomy | 4 | 2009 | 58 | 0.110 |
Why?
| | Time Factors | 9 | 2025 | 6851 | 0.110 |
Why?
| | Pilot Projects | 2 | 2013 | 1765 | 0.110 |
Why?
| | Hospitalization | 1 | 2025 | 2235 | 0.110 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.110 |
Why?
| | Leiomyoma | 1 | 2015 | 55 | 0.110 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 108 | 0.110 |
Why?
| | Aptitude | 1 | 2014 | 37 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 27 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1482 | 0.110 |
Why?
| | Ulcer | 1 | 2014 | 34 | 0.110 |
Why?
| | Incidence | 6 | 2025 | 2747 | 0.110 |
Why?
| | Colectomy | 1 | 2014 | 102 | 0.100 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1224 | 0.100 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 278 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 2030 | 0.100 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 26 | 0.100 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 24 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 329 | 0.100 |
Why?
| | Hemorrhage | 1 | 2018 | 747 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 228 | 0.100 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 143 | 0.100 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 12 | 0.100 |
Why?
| | Contrast Media | 1 | 1995 | 463 | 0.090 |
Why?
| | Recurrence | 4 | 2020 | 1084 | 0.090 |
Why?
| | Risk Assessment | 8 | 2016 | 3433 | 0.090 |
Why?
| | Cholecystitis | 1 | 1992 | 23 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 439 | 0.090 |
Why?
| | Health Care Costs | 1 | 2015 | 418 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2012 | 492 | 0.090 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 3 | 0.090 |
Why?
| | Diverticulum | 1 | 1991 | 12 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 1991 | 7 | 0.090 |
Why?
| | Digestive System Diseases | 1 | 2011 | 26 | 0.090 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1482 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 28 | 0.090 |
Why?
| | Sensation | 1 | 1991 | 56 | 0.090 |
Why?
| | Chest Pain | 1 | 1991 | 96 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2851 | 0.080 |
Why?
| | Hypotension | 1 | 2011 | 121 | 0.080 |
Why?
| | Deglutition | 1 | 1991 | 71 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 598 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1110 | 0.080 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 5 | 0.080 |
Why?
| | Image Enhancement | 1 | 2011 | 191 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1991 | 151 | 0.080 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.080 |
Why?
| | United States | 10 | 2018 | 14938 | 0.080 |
Why?
| | Bile | 1 | 2009 | 25 | 0.080 |
Why?
| | Cholecystostomy | 1 | 1989 | 3 | 0.080 |
Why?
| | Disease Progression | 5 | 2017 | 2749 | 0.080 |
Why?
| | Length of Stay | 5 | 2025 | 1238 | 0.080 |
Why?
| | Odds Ratio | 4 | 2016 | 1044 | 0.080 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 77 | 0.080 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 89 | 0.080 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 38 | 0.070 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 51 | 0.070 |
Why?
| | Equipment Safety | 2 | 2009 | 37 | 0.070 |
Why?
| | Tumor Burden | 3 | 2015 | 309 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 52 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 157 | 0.070 |
Why?
| | Cholangiography | 1 | 2008 | 9 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 3987 | 0.070 |
Why?
| | Adolescent | 8 | 2025 | 21564 | 0.070 |
Why?
| | Anesthetics | 1 | 2009 | 98 | 0.070 |
Why?
| | Choledocholithiasis | 1 | 2008 | 19 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 331 | 0.070 |
Why?
| | Video Recording | 3 | 2014 | 181 | 0.070 |
Why?
| | Ultrasonography | 4 | 1996 | 745 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 674 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 406 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 304 | 0.070 |
Why?
| | Acute Disease | 4 | 2008 | 994 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 2004 | 187 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2073 | 0.060 |
Why?
| | Hyperplasia | 2 | 2019 | 176 | 0.060 |
Why?
| | Pleural Diseases | 1 | 2006 | 23 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 32 | 0.060 |
Why?
| | Prognosis | 5 | 2017 | 3984 | 0.060 |
Why?
| | Research Design | 2 | 2016 | 1118 | 0.060 |
Why?
| | Delphi Technique | 2 | 2017 | 289 | 0.060 |
Why?
| | Pain | 2 | 2022 | 777 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 10 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 32 | 0.060 |
Why?
| | Cohort Studies | 5 | 2020 | 5697 | 0.050 |
Why?
| | Health Care Surveys | 3 | 2014 | 565 | 0.050 |
Why?
| | Hypoxia | 1 | 2011 | 1149 | 0.050 |
Why?
| | Cyst Fluid | 2 | 2018 | 21 | 0.050 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 73 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 168 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 5803 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2023 | 36 | 0.050 |
Why?
| | Midazolam | 1 | 2023 | 69 | 0.050 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 138 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 638 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 60 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 350 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 21 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 35 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 115 | 0.050 |
Why?
| | Animals | 3 | 2020 | 37217 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 548 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 248 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 17 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 272 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1292 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2681 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 211 | 0.040 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 29 | 0.040 |
Why?
| | Endoscopes | 2 | 1998 | 17 | 0.040 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 57 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2698 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 249 | 0.040 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 120 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 26 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 36 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1235 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 49 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 74 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 56 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 85 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 40 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2018 | 980 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 12 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 324 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1034 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 73 | 0.040 |
Why?
| | Probability | 2 | 2009 | 308 | 0.040 |
Why?
| | General Surgery | 1 | 2000 | 176 | 0.040 |
Why?
| | Radiology | 1 | 2000 | 164 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 44 | 0.030 |
Why?
| | Electrodes | 1 | 1998 | 113 | 0.030 |
Why?
| | Resuscitation | 1 | 2000 | 275 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1374 | 0.030 |
Why?
| | Swine | 1 | 2020 | 801 | 0.030 |
Why?
| | Reference Standards | 1 | 2018 | 184 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2018 | 50 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1323 | 0.030 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 95 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 433 | 0.030 |
Why?
| | Granulation Tissue | 1 | 2016 | 7 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 96 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 174 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 75 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 83 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 16 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 14 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 202 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 16 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1089 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 32 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2727 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 28 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 12 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 6 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1935 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 39 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 82 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2844 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 117 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 110 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 167 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 86 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 126 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 87 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11158 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 647 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 416 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 222 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 273 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 80 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 273 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3637 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1092 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 328 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 82 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 675 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 685 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 218 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 279 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 202 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 163 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 562 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 428 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 447 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 676 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1296 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 916 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 608 | 0.020 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 5 | 0.020 |
Why?
| | Radio Waves | 2 | 2003 | 17 | 0.020 |
Why?
| | Colic | 1 | 1992 | 8 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 745 | 0.020 |
Why?
| | Mediastinum | 1 | 2012 | 22 | 0.020 |
Why?
| | Esophagitis | 1 | 2013 | 68 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2013 | 125 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 853 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 789 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1739 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 427 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 63 | 0.020 |
Why?
| | Palliative Care | 1 | 2019 | 815 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 202 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| | Edema | 1 | 2011 | 129 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 196 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 316 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 367 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Methods | 1 | 1989 | 68 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 38 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 841 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1269 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 553 | 0.020 |
Why?
| | Injections | 1 | 2010 | 189 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 799 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 561 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 11 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 67 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 896 | 0.020 |
Why?
| | Light | 1 | 2011 | 390 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 273 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 393 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 377 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 148 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 431 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 185 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 144 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 262 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3256 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 180 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 148 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 948 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 239 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 333 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 126 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1309 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 2072 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2008 | 140 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1317 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 620 | 0.010 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 5520 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1731 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1656 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 94 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9574 | 0.010 |
Why?
| | Child | 2 | 2018 | 21921 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2044 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 60 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 579 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 6 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 1157 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 48 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 88 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 996 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 110 | 0.010 |
Why?
| | Safety | 1 | 1998 | 347 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 32 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 143 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 118 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 11 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 6 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 612 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 116 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 104 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 174 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1805 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 6829 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|